Total Funding
53
58
Total FundingSeries A raised
Growth Score 53 in past quarter
-3 pts
Heat Score 58 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
40799
Aidence provides AI solutions for the lung cancer pathway.
Mark-Jan Harte: Co-Founder - CEO- Theo Gough: Chief Technology Officer
RadNet
About the Company
Aidence rallies 80+ data scientists, software engineers, medical, regulatory, and business professionals to provide intelligent software for the lung cancer pathway. Their first clinical application is Veye Lung Nodules, an AI solution for pulmonary nodule management on CTs. Veye is running in routine practice and lung cancer screening programmes
across Europe.